Please use this identifier to cite or link to this item:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/85082
Full metadata record
???org.dspace.app.webui.jsptag.ItemTag.dcfield??? | Value | Language |
---|---|---|
dc.contributor.advisor | 陳明汝(Ming-Ju Chen) | |
dc.contributor.author | Chun-Ting Lee | en |
dc.contributor.author | 李俊霆 | zh_TW |
dc.date.accessioned | 2023-03-19T22:42:29Z | - |
dc.date.copyright | 2022-10-05 | |
dc.date.issued | 2022 | |
dc.date.submitted | 2022-08-15 | |
dc.identifier.citation | 1. World Health Organization. (2022). World health statistics 2022: monitoring health for the SDGs, sustainable development goals. 2. Danaei, G., Yuan, L., Singh, G. M., Carnahan, E., Stevens, G. A., Cowan, M. J., ... & Kobayashi, J. (2014). Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. 3. Al-Mawali, A. (2015). Non-communicable diseases: shining a light on cardiovascular disease, Oman’s biggest killer. Oman medical journal, 30(4), 227. 4. United Nation. (n.d.). Goal 3: ensure healthy lives and promote well-being for all at all ages. Retrieved May 15, 2022, from https://www.un.org/sustainabledevelopment/health/ 5. Amini, M., Zayeri, F., & Salehi, M. (2021). Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017. BMC Public Health, 21(1), 1-12. 6. Roth, G. A., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., ... & Borschmann, R. (2018). Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392(10159), 1736-1788. 7. Beilin, L. J. (1999). Lifestyle and hypertension—an overview. Clinical and experimental hypertension, 21(5-6), 749-762. 8. Zhao, D., Qi, Y., Zheng, Z., Wang, Y., Zhang, X. Y., Li, H. J., ... & Liu, J. (2011). Dietary factors associated with hypertension. Nature Reviews Cardiology, 8(8), 456-465. 9. Matsubara, F., Ueno, H., Tadano, K., Suyama, T., Imaizumi, K., Suzuki, T., ... & Saruta, T. (2002). Effects of GABA supplementation on blood pressure and safety in adults with mild hypertension. Japanese Pharmacology and Therapeutics, 30(11), 963-972. 10. Shimada, M., Hasegawa, T., Nishimura, C., Kan, H., Kanno, T., Nakamura, T., & Matsubayashi, T. (2009). Anti-hypertensive effect of γ-aminobutyric acid (GABA)-rich Chlorella on high-normal blood pressure and borderline hypertension in placebo-controlled double blind study. Clinical and Experimental Hypertension, 31(4), 342-354. 11. Takahashi, H., Tiba, M., Iino, M., & Takayasu, T. (1955). The effect of γ-animobuic acid on blood pressure. The Japanese journal of physiology, 5, 334-341. 12. Oh, S. H., Moon, Y. J., & Oh, C. H. (2003). γ-Aminobutyric acid (GABA) content of selected uncooked foods. Preventive Nutrition and Food Science, 8(1), 75-78. 13. Yu, L., Han, X., Cen, S., Duan, H., Feng, S., Xue, Y., ... & Chen, W. (2020). Beneficial effect of GABA-rich fermented milk on insomnia involving regulation of gut microbiota. Microbiological Research, 233, 126409. 14. Kanklai, J., Somwong, T. C., Rungsirivanich, P., & Thongwai, N. (2020). Screening of GABA-producing lactic acid bacteria from thai fermented foods and probiotic potential of levilactobacillus brevis F064A for GABA-fermented mulberry juice production. Microorganisms, 9(1), 33. 15. Park, K. B., & Oh, S. H. (2005). Production and characterization of GABA rice yogurt. Food Science and Biotechnology, 14(4), 518-522. 16. Oketch-Rabah, H. A., Madden, E. F., Roe, A. L., & Betz, J. M. (2021). United States Pharmacopeia (USP) safety review of gamma-aminobutyric acid (GABA). Nutrients, 13(8), 2742. 17. Waltz, E. (2022). GABA-enriched tomato is first CRISPR-edited food to enter market. Nature biotechnology, 40(1), 9-11. 18. Doudna, J. A., & Charpentier, E. (2014). The new frontier of genome engineering with CRISPR-Cas9. Science, 346(6213), 1258096. 19. Nonaka, S., Arai, C., Takayama, M., Matsukura, C., & Ezura, H. (2017). Efficient increase of ɣ-aminobutyric acid (GABA) content in tomato fruits by targeted mutagenesis. Scientific reports, 7(1), 1-14. 20. Schmidt, S. M., Belisle, M., & Frommer, W. B. (2020). The evolving landscape around genome editing in agriculture: Many countries have exempted or move to exempt forms of genome editing from GMO regulation of crop plants. EMBO reports, 21(6), e50680. 21. European Commission. (2021). Study on the Status of New Genomic Techniques under Union Law and in Light of the Court of Justice Ruling in Case C-528/16. 22. Rozin, P., Spranca, M., Krieger, Z., Neuhaus, R., Surillo, D., Swerdlin, A., & Wood, K. (2004). Preference for natural: instrumental and ideational/moral motivations, and the contrast between foods and medicines. Appetite, 43(2), 147-154. 23. Bateson, W., & Mendel, G. (2013). Mendel's principles of heredity. Courier Corporation. 24. Kumar, M., Yusuf, M. A., & Nigam, M. (2018). An update on genetic modification of chickpea for increased yield and stress tolerance. Molecular biotechnology, 60(8), 651-663. 25. Shetty, M. J., Chandan, K., Krishna, H. C., & Aparna, G. S. (2018). Genetically modified crops: An overview. Journal of Pharmacognosy and Phytochemistry, 7(1), 2405-2410. 26. Rozin, P. (2005). The meaning of “natural” process more important than content. Psychological science, 16(8), 652-658. 27. Tsatsakis, A. M., Nawaz, M. A., Kouretas, D., Balias, G., Savolainen, K., Tutelyan, V. A., ... & Chung, G. (2017). Environmental impacts of genetically modified plants: a review. Environmental research, 156, 818-833. 28. World Health Organization. (2014, May 1). Food, genetically modified. World Health Organization. Retrieved May 22, 2022, from https://www.who.int/news-room/questions-and-answers/item/food-genetically-modified 29. Shew, A. M., Nalley, L. L., Snell, H. A., Nayga Jr, R. M., & Dixon, B. L. (2018). CRISPR versus GMOs: Public acceptance and valuation. Global food security, 19, 71-80. 30. Marette, S., Disdier, A. C., & Beghin, J. C. (2021). A comparison of EU and US consumers’ willingness to pay for gene-edited food: Evidence from apples. Appetite, 159, 105064. 31. Muringai, V., Fan, X., & Goddard, E. (2020). Canadian consumer acceptance of gene‐edited versus genetically modified potatoes: A choice experiment approach. Canadian Journal of Agricultural Economics/Revue canadienne d'agroeconomie, 68(1), 47-63. 32. 109 Annual Unit Budget Evaluation Report of the Food and Drug Administration of the Ministry of Health and Welfare and the National Health Administration. Legislative Yuan, Republic of China. (2019, September). Retrieved May 22, 2022, from https://www.ly.gov.tw/Pages/Detail.aspx?nodeid=33464&pid=187044 33. Garden, H., & Winickoff, D. (2018). Gene editing for advanced therapies: Governance, policy and society. 34. Chen, M. F. (2011). The gender gap in food choice motives as determinants of consumers' attitudes toward GM foods in Taiwan. British Food Journal. 35. Vandermoere, F., Blanchemanche, S., Bieberstein, A., Marette, S., & Roosen, J. (2011). The public understanding of nanotechnology in the food domain: the hidden role of views on science, technology, and nature. Public Understanding of Science, 20(2), 195-206. 36. Yang, Y., & Hobbs, J. E. (2020). Supporters or opponents: will cultural values shape consumer acceptance of gene editing?. Journal of Food Products Marketing, 26(1), 17-37. 37. Honkanen, P., & Frewer, L. (2009). Russian consumers’ motives for food choice. Appetite, 52(2), 363-371. 38. Gobo, G. (2004). Sampling, representativeness and generalizability. Qualitative research practice, 405, 426. 39. Haerpfer, C., Inglehart, R., Moreno, A., Welzel, C., Kizilova, K., Diez-Medrano J., M. Lagos, P. Norris, E. Ponarin & B. Puranen (eds.). 2022. World Values Survey: Round Seven - Country-Pooled Datafile Version 4.0. Madrid, Spain & Vienna, Austria: JD Systems Institute & WVSA Secretariat. doi:10.14281/18241.18 40. Council of Canadian Academies. (2014, August 28). Science Culture: Where Canada Stands. The Expert Panel on the State of Canada’s Science Culture. CCA. Retrieved May 27, 2022, from https://cca-reports.ca/reports/science-culture-where-canada-stands/ 41. House, L. O., Lusk, J., Jaeger, S. R., Traill, B., Moore, M., Valli, C., ... & Yee, W. (2004). Objective and subjective knowledge: Impacts on consumer demand for genetically modified foods in the United States and the European Union. 42. Roininen, K., Lähteenmäki, L., & Tuorila, H. (1999). Quantification of consumer attitudes to health and hedonic characteristics of foods. Appetite, 33(1), 71-88. 43. NTU-Singapore. (2018). Integrated Human Practice. Team: NTU-Singapore/IHP. Retrieved July 29, 2022, from https://2018.igem.org/Team:NTU-Singapore/IHP | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/85082 | - |
dc.description.abstract | 在世界經濟快速發展的時代,人民生活水準不斷提高,健康議題越來越受到重視。高血壓是導致許多慢性病的危險因子,其中的心血管疾病更是長年以來位居於世界前十大死因。隨著全球人口持續成長,患有高血壓的人數在近三十年來不斷增加,被認定為全球疾病負擔的首位,因此降低高血壓的盛行率已經成為全球永續發展的重要目標。雖然高血壓可以通過藥物治療得到改善,但在多數人無意識到自身患有高血壓而未接受治療的情況下,對降低高血壓盛行率的成效有限。相較之下,以提高日常飲食中有助於緩解高血壓成分的攝取是更具有潛力的方法。番茄是國際上重要的經濟作物,番茄中的γ-胺基丁酸是具有降低血壓功能的成分。目前透過基因編輯技術(精準育種)培育出富含γ-胺基丁酸的番茄品種,儘管社會對於基因科技的應用有所反對,但由於基因編輯技術與傳統育種的作物並無差異,其充滿發展性的前景促使許多國家開始評估社會的接受度,並且研擬相關法規草案,然而在臺灣很少有相關的研究和討論。因此本研究聚焦在基因編輯蕃茄與其抗高血壓的功效,透過前導問卷的方式收集與評估台灣社會大眾對於基因編輯食品和科技的認知,希望促進相關議題的討論和提供有助於立法的意見。本研究總共收集到103 份來自各年齡層的樣本,通過評估與比對各國消費者對於科技發展在不同面向的態度,我們認為收集到的問卷樣本是來自於對科技發展有相對正面態度的消費者,但與其他科技接受度更高的國家相比,仍然存在明顯的進步空間。在調查消費者對於育種的認知時,有超過半數的消費者表示不熟悉基因編輯,但在安全性、天然性、道德性和永續性等方面來看,消費者對基因編輯的接受度皆比基因改造來得高,而天然性可能會是基因編輯是否被大眾接受的關鍵。除此之外,我們發現女性在基因編輯技術的接受度有標準比男性更嚴苛,而學生族群在安全和道德方面比起非學生族群更能接受基因編輯,但在天然性和永續性方面則不然。令我們意外的是,研究結果顯示年齡在 31 至 50 歲之間的消費者比起基因編輯反而更能夠接受基因改造。另外,我們透過提供有助於理解基因編輯番茄育種目的之訊息,評估消費者對基因編輯番茄的接受度。根據我們的研究結果,有接近半數的消費者會擔心自己有高血壓的症狀,並且願意吃由基因編輯技術育種之番茄。此外,消費者對基因編輯技術在其他領域的應用是有所期待的。然而目前尚有將近五分之一的消費者表示自己對於基因編輯技術並不了解,因此整體社會仍需對作物育種和基因技術進行完善的教育與推廣,以提升接受度與共識。 | zh_TW |
dc.description.abstract | The number of people suffering from hypertension has been increasing in recent years. Because it leads to severe cardiovascular diseases, reducing the prevalence of hypertension has become a global unmet need. Although hypertension could be well controlled through medical treatment, many people are unaware of having hypertension and not under effective treatment. In contrast, dietary approaches have more potential to relieve hypertension in our daily life. Tomatoes are a common healthy food containing γ-aminobutyric acid (GABA), which can reduce blood pressure in hypertension conditions. For health purposes, tomatoes with high levels of GABA have been bred through genome editing technology. However, previous research has shown people's attitudes against genetic technology. Due to the promising development of genome editing technology, several countries have investigated public perception and started establishing acts, while little research and discussion could be found in Taiwan. Therefore, our study used tomatoes to assess public perception of genome-edited foods and genome editing technology as a pilot survey in Taiwan. We have received 103 online responses from all ages of the consumers. Through comparing consumer’s attitudes toward science and technology among different countries, we believed that our respondents might be relatively receptive to science and technology in the population, but there is still a gap between countries with high acceptance. Moreover, over half of the consumers feel unfamiliar with genome editing. Nevertheless, consumers are slightly more accepting of genome editing than genetic modification in the aspect of safety, naturalness, ethic, and sustainability. Among, naturalness might be the most critical point for consumers to accept. We also analyze the public perception of breeding methods based on the different socio-demographic characteristics and found that females might have stricter standards for genome editing technology. Besides, students are more receptive to genome editing technology than non-students in terms of safety and ethic but not naturalness and sustainability. To our surprise, consumers from 31 to 50 years old are more accepting of genetic modification than genome editing in all aspects. Then, we assessed the social acceptability of genome-edited tomatoes enriched with GABA by providing brief information. Based on our study, consumers are worried about having hypertension and willing to eat high-GABA tomatoes despite genome editing technology. In addition, consumers are expecting more applications in other areas. In conclusion, nearly one in five consumers do not understand genome editing technology, and thus, thorough education about breeding methods and genetic technology is essentially required. | en |
dc.description.provenance | Made available in DSpace on 2023-03-19T22:42:29Z (GMT). No. of bitstreams: 1 U0001-1208202210412300.pdf: 937607 bytes, checksum: fa79bd0350fdae29d4ffd0ac1fafe696 (MD5) Previous issue date: 2022 | en |
dc.description.tableofcontents | 口試委員會審定書 .....………………………………………………………………… i 誌謝 …………………………………………………………………………………… ii 中文摘要 …………………………………….…………….……….………………… iii ABSTRACT …………………………………………………………………………… v TABLE OF CONTENTS …………………………….……….……………………… vii LIST OF FIGURES …………………………………………………………………… ix LIST OF TABLES ……………………………….…………………………….………. x Chapter 1 Introduction …………………………………………………………… 1 1.1 Sustainable Development Goals to reduce global hypertension .…………… 1 1.2 Dietary approaches with γ-aminobutyric acid intake ……..………………… 2 1.3 Genome-edited tomatoes enriched for γ-aminobutyric acid ……..……..…… 2 1.4 The controversy of innovative genome editing technology ………………… 4 1.5 Social acceptability of genome-edited food ………………………………… 4 Chapter 2 Objectives ……………………………………………………………… 6 2.1 Hypertension prevalence and genome editing in Taiwan …………………… 6 2.2 Research aim and hypothesis ………..……………………………….……… 6 Chapter 3 Methods ………….……….…………………………….……………… 8 3.1 Multi sampling and data collection …………….…………………………… 8 3.2 Survey design and measurement ………………………………….………… 8 Chapter 4 Results ………………………………………………………………… 11 4.1 Socio-demographic characteristics ………………………………………… 11 4.2 Public perceptions toward science and technologies ………….…………… 12 4.3 Perception toward breeding methods ……………………………………… 14 4.4 Willingness to eat GABA-enriched tomatoes in Taiwan …….…….……… 16 4.5 Public perception about the benefits and risks of genome editing ………… 18 Chapter 5 Discussion ……………………………….……….…………………… 20 FIGURE ……………………………………………………………………….……… 22 TABLE ……..………………….……………………………………………………… 37 REFERENCE ……………………….………………………………………………… 38 APPENDIX …………………………………………………………………………… 45 | |
dc.language.iso | en | |
dc.title | 台灣消費者對以番茄為例之基因編輯食品的認知研究 | zh_TW |
dc.title | Consumer’s Perception towards Genome-Edited Food in Taiwan: Evidence from Tomato | en |
dc.type | Thesis | |
dc.date.schoolyear | 110-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 劉嚞睿(Je-Ruei Liu),沈湯龍(Tang-Long Shen),張慶國(Chin-Kuo Chang),周涵怡(Han-Yi Chou) | |
dc.subject.keyword | 高γ-胺基丁酸番茄,γ-氨基丁酸,基因編輯技術,高血壓,公眾認知,社會接受度, | zh_TW |
dc.subject.keyword | GABA-enriched tomatoes,γ-aminobutyric acid,genome editing technology,hypertension,public perception,social acceptability, | en |
dc.relation.page | 48 | |
dc.identifier.doi | 10.6342/NTU202202330 | |
dc.rights.note | 同意授權(限校園內公開) | |
dc.date.accepted | 2022-08-15 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 國際三校農業生技與健康醫療碩士學位學程 | zh_TW |
dc.date.embargo-lift | 2022-10-05 | - |
Appears in Collections: | 國際三校農業生技與健康醫療碩士學位學程 |
Files in This Item:
File | Size | Format | |
---|---|---|---|
U0001-1208202210412300.pdf Access limited in NTU ip range | 915.63 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.